Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in patients with advanced non-small cell lung cancer

Transl Lung Cancer Res. 2014 Dec;3(6):403-5. doi: 10.3978/j.issn.2218-6751.2014.09.02.
No abstract available